Cytochrome P-450 CYP2B6 Inhibitors

Known as: Inhibitors, P450 CYP2B6, CYP2B6 Inhibitors, P450, P450 CYP2B6 Inhibitors 
Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP2B6.
National Institutes of Health

Topic mentions per year

Topic mentions per year

2008-2014
0120082014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Efavirenz (EFV) therapeutic response and toxicity are associated with high inter-individual variability attributed to variation… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
2014
2014
The glycogen synthase kinase-3 inhibitor LY2090314 specifically impaired CYP2B6 activity during in vitro evaluation of cytochrome… (More)
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2012
2012
BACKGROUND Drugs with complex pharmacology are used in the management of drug use disorder (DUD) and HIV/AIDS in Malaysia and in… (More)
Is this relevant?
2011
2011
Efavirenz, an antiretroviral medicine, is extensively metabolized by cytochrome P450 2B6 (CYP2B6), UDP-glucuronosyltransferase… (More)
  • figure 1
Is this relevant?
2010
2010
BACKGROUND Cytochrome P450 2B6 (CYP2B6) metabolizes efavirenz and nevirapine, the major core antiretroviral drugs for HIV in… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
Is this relevant?
2008
2008
BACKGROUND Our main objectives were to study the population pharmacokinetics of efavirenz and to explore the adequacy of dosing… (More)
Is this relevant?